Compare Natco Pharma with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA J.B.CHEMICALS NATCO PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 32.3 37.7 85.6% View Chart
P/BV x 4.6 7.0 65.4% View Chart
Dividend Yield % 0.7 0.2 438.7%  

Financials

 NATCO PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    NATCO PHARMA
Mar-19
J.B.CHEMICALS
Mar-18
NATCO PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs849363 233.8%   
Low Rs557255 218.4%   
Sales per share (Unadj.) Rs573.8169.1 339.3%  
Earnings per share (Unadj.) Rs176.016.6 1,060.3%  
Cash flow per share (Unadj.) Rs198.223.4 846.4%  
Dividends per share (Unadj.) Rs6.252.00 312.5%  
Dividend yield (eoy) %0.90.6 137.4%  
Book value per share (Unadj.) Rs842.7172.5 488.6%  
Shares outstanding (eoy) m36.5083.57 43.7%   
Bonus/Rights/Conversions BBBB-  
Price / Sales ratio x1.21.8 67.0%   
Avg P/E ratio x4.018.6 21.5%  
P/CF ratio (eoy) x3.513.2 26.9%  
Price / Book Value ratio x0.81.8 46.6%  
Dividend payout %3.612.0 29.5%   
Avg Mkt Cap Rs m25,66025,827 99.4%   
No. of employees `0005.03.8 131.4%   
Total wages/salary Rs m3,5592,511 141.7%   
Avg. sales/employee Rs Th4,225.33,747.4 112.8%   
Avg. wages/employee Rs Th718.0665.7 107.9%   
Avg. net profit/employee Rs Th1,295.9367.8 352.4%   
INCOME DATA
Net Sales Rs m20,94514,135 148.2%  
Other income Rs m1,302366 355.9%   
Total revenues Rs m22,24714,501 153.4%   
Gross profit Rs m7,9482,178 364.9%  
Depreciation Rs m810570 142.2%   
Interest Rs m19335 553.0%   
Profit before tax Rs m8,2471,940 425.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,823552 330.1%   
Profit after tax Rs m6,4241,387 463.1%  
Gross profit margin %37.915.4 246.2%  
Effective tax rate %22.128.5 77.6%   
Net profit margin %30.79.8 312.5%  
BALANCE SHEET DATA
Current assets Rs m23,47210,470 224.2%   
Current liabilities Rs m7,2872,749 265.1%   
Net working cap to sales %77.354.6 141.5%  
Current ratio x3.23.8 84.6%  
Inventory Days Days9255 167.0%  
Debtors Days Days8878 113.6%  
Net fixed assets Rs m18,6485,811 320.9%   
Share capital Rs m365167 218.4%   
"Free" reserves Rs m34,52514,248 242.3%   
Net worth Rs m30,76014,416 213.4%   
Long term debt Rs m00-   
Total assets Rs m43,03117,649 243.8%  
Interest coverage x43.756.6 77.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.8 60.8%   
Return on assets %15.48.1 190.8%  
Return on equity %20.99.6 217.0%  
Return on capital %27.413.7 200.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m11,5366,164 187.2%   
Fx outflow Rs m2,9391,334 220.2%   
Net fx Rs m8,5974,829 178.0%   
CASH FLOW
From Operations Rs m6,6881,231 543.5%  
From Investments Rs m-6,122-208 2,941.9%  
From Financial Activity Rs m-509-595 85.5%  
Net Cashflow Rs m66427 15.5%  

Share Holding

Indian Promoters % 52.0 55.4 93.9%  
Foreign collaborators % 1.5 0.3 490.0%  
Indian inst/Mut Fund % 7.8 3.4 231.3%  
FIIs % 16.6 3.9 426.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 37.0 70.3%  
Shareholders   25,395 30,437 83.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   GSK PHARMA  ASTRAZENECA PHARMA  DIVIS LABORATORIES  IPCA LABS  JUBILANT PHARMOVA   

Compare NATCO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat, GAIL and UPL Among Top Nifty Gainers(Closing)

Indian share markets continued their volatile trend during closing hours today and ended their day on a flat note.

Related Views on News

NATCO PHARMA Share Price Up by 7%; BSE HEALTHCARE Index Up 0.8% (Market Updates)

Mar 8, 2021 | Updated on Mar 8, 2021

NATCO PHARMA share price is trading up by 7% and its current market price is Rs 894. The BSE HEALTHCARE is up by 0.8%. The top gainers in the BSE HEALTHCARE Index is NATCO PHARMA (up 6.7%). The top losers are ABBOTT INDIA (down 0.1%) and SYNGENE INTERNATIONAL (down 0.1%).

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Mar 8, 2021 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - VENUS REMEDIES COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS